BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Al-Moundhri MS, Al-Kindi M, Al-Nabhani M, Al-Bahrani B, Burney IA, Al-Madhani A, Ganguly SS, Tanira M. NAT2 polymorphism in Omani gastric cancer patients-risk predisposition and clinicopathological associations. World J Gastroenterol 2007; 13(19): 2697-2702 [PMID: 17569138 DOI: 10.3748/wjg.v13.i19.2697]
URL: https://www.wjgnet.com/1007-9327/full/v13/i19/2697.htm
Number Citing Articles
1
Kouichi Kurose, Emiko Sugiyama, Yoshiro Saito. Population Differences in Major Functional Polymorphisms of Pharmacokinetics/pharmacodynamics-related Genes in Eastern Asians and Europeans: Implications in the Clinical Trials for Novel Drug DevelopmentDrug Metabolism and Pharmacokinetics 2012; 27(1): 9 doi: 10.2133/dmpk.DMPK-11-RV-111
2
Giuliano Di Pietro, Sandra Rocha Gadelha, Sandra Mara Bispo Sousa, Paulo Roberto Santana de Melo, Fabricio Rios Santos. N-acetyltransferase 2: Slow, intermediate or fast? A booming question of the molecular epidemiology in cancer researchOpen Journal of Genetics 2012; 2(04): 221 doi: 10.4236/ojgen.2012.24028
3
Jian Yu, Yue Deng, Jian-Ping Chen. N-Acetyltransferase 2 status and gastric cancer risk: a meta-analysisTumor Biology 2014; 35(7): 6861 doi: 10.1007/s13277-014-1847-7
4
Yan Wei Zhang, Sang‐Yong Eom, Yong‐Dae Kim, Young‐Jin Song, Hyo‐Yung Yun, Joo‐Seung Park, Sei‐Jin Youn, Byung Sik Kim, Heon Kim, David W. Hein. Effects of dietary factors and the NAT2 acetylator status on gastric cancer in KoreansInternational Journal of Cancer 2009; 125(1): 139 doi: 10.1002/ijc.24328
5
Xu Zhong, Cao Hui, Wu Xiao-Ling, Li Yan, Luo Na. NAT2 Polymorphism and Gastric Cancer Susceptibility: A Meta-analysisArchives of Medical Research 2010; 41(4): 275 doi: 10.1016/j.arcmed.2010.06.001
6
Fang-Shuo Tian, Li Shen, Yang-Wu Ren, Yue Zhang, Zhi-Hua Yin, Bao-Sen Zhou. N-Acetyltransferase 2 Gene Polymorphisms are Associated with Susceptibility to Cancer: a Meta-analysisAsian Pacific Journal of Cancer Prevention 2014; 15(14): 5621 doi: 10.7314/APJCP.2014.15.14.5621
7
Naazneen Khan, Veena Pande, Aparup Das. NAT2 Sequence Polymorphisms and Acetylation ProFiles in Indians Pharmacogenomics 2013; 14(3): 289 doi: 10.2217/pgs.13.2
8
Jesse D. Troy, Joel L. Weissfeld, Brenda Diergaarde, Ada O. Youk, Shama C. Buch, Marjorie Romkes, Jennifer R. Grandis. Polymorphisms in NAT2 and GSTP1 are associated with survival in oral and oropharyngeal cancerCancer Epidemiology 2013; 37(4): 505 doi: 10.1016/j.canep.2013.02.009
9
Minatsu Kobayashi, Tetsuya Otani, Motoki Iwasaki, Shusuke Natsukawa, Kozo Shaura, Yoichi Koizumi, Yoshio Kasuga, Hiromi Sakamoto, Teruhiko Yoshida, Shoichiro Tsugane. Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of stomach cancer: a hospital-based case-control study in JapanGastric Cancer 2009; 12(4): 198 doi: 10.1007/s10120-009-0523-x